Evaluating the Impact of BoNT-A Injections on Facial Expressions: A Deep Learning Analysis.
Abstract
[BACKGROUND] Botulinum toxin type A (BoNT-A) injections are widely administered for facial rejuvenation, but their effects on facial expressions remain unclear.
[OBJECTIVES] In this study, we aimed to objectively measure the impact of BoNT-A injections on facial expressions with deep learning techniques.
[METHODS] One hundred eighty patients age 25 to 60 years who underwent BoNT-A application to the upper face were included. Patients were photographed with neutral, happy, surprised, and angry expressions before and 14 days after the procedure. A convolutional neural network (CNN)-based facial emotion recognition (FER) system analyzed 1440 photographs with a hybrid data set of clinical images and the Karolinska Directed Emotional Faces (KDEF) data set.
[RESULTS] The CNN model accurately predicted 90.15% of the test images. Significant decreases in the recognition of angry and surprised expressions were observed postinjection (P < .05), with no significant changes in happy or neutral expressions (P > .05). Angry expressions were often misclassified as neutral or happy (P < .05), and surprised expressions were more likely to be perceived as neutral (P < .05).
[CONCLUSIONS] Deep learning can effectively assess the impact of BoNT-A injections on facial expressions, providing more standardized data than traditional surveys. BoNT-A may reduce the expression of anger and surprise, potentially leading to a more positive facial appearance and emotional state. Further studies are needed to understand the broader implications of these changes.
[OBJECTIVES] In this study, we aimed to objectively measure the impact of BoNT-A injections on facial expressions with deep learning techniques.
[METHODS] One hundred eighty patients age 25 to 60 years who underwent BoNT-A application to the upper face were included. Patients were photographed with neutral, happy, surprised, and angry expressions before and 14 days after the procedure. A convolutional neural network (CNN)-based facial emotion recognition (FER) system analyzed 1440 photographs with a hybrid data set of clinical images and the Karolinska Directed Emotional Faces (KDEF) data set.
[RESULTS] The CNN model accurately predicted 90.15% of the test images. Significant decreases in the recognition of angry and surprised expressions were observed postinjection (P < .05), with no significant changes in happy or neutral expressions (P > .05). Angry expressions were often misclassified as neutral or happy (P < .05), and surprised expressions were more likely to be perceived as neutral (P < .05).
[CONCLUSIONS] Deep learning can effectively assess the impact of BoNT-A injections on facial expressions, providing more standardized data than traditional surveys. BoNT-A may reduce the expression of anger and surprise, potentially leading to a more positive facial appearance and emotional state. Further studies are needed to understand the broader implications of these changes.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | facial rejuvenation
|
안면거상술 | dict | 1 | |
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 약물 | [BACKGROUND] Botulinum toxin type A
|
scispacy | 1 | ||
| 약물 | [OBJECTIVES]
|
scispacy | 1 | ||
| 약물 | BoNT-A
→ Botulinum toxin type A
|
scispacy | 1 | ||
| 약물 | KDEF
→ Karolinska Directed Emotional Faces
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] Deep
|
scispacy | 1 | ||
| 질환 | anger
|
C0002957
Anger
|
scispacy | 1 | |
| 기타 | BoNT-A
→ Botulinum toxin type A
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | neural network
|
scispacy | 1 |
MeSH Terms
Humans; Facial Expression; Botulinum Toxins, Type A; Adult; Deep Learning; Middle Aged; Female; Male; Emotions; Neuromuscular Agents; Cosmetic Techniques; Rejuvenation; Photography; Skin Aging
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.